Skip to content

Blackberry Intake and Biomarkers of Cancer Risk

Blackberry Intake and Biomarkers of Cancer Risk

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01293617
Enrollment
52
Registered
2011-02-10
Start date
2011-01-31
Completion date
2011-04-30
Last updated
2011-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

Berry components have been shown to influence cancer processes in cell culture studies. The investigators will conduct a study to investigate if blackberries influence the same cancer processes in a human feeding study.

Interventions

300 g blackberries daily for 5 days

OTHERGelatin

300 g gelatin per day for 5 days

Sponsors

United States Department of Agriculture (USDA)
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Non-smoking men and women * Aged 40-75 * BMI 19-38 kg/m2

Exclusion criteria

* Younger then 40 ears old or older than 75 years old * BMI less than 19 or greater than 38 * Use of blood-thinning medications such as warfarin, dicumarol, or anisinidione * Presence of kidney disease, liver disease, gout, certain cancers, untreated thyroid, gastrointestinal, other metabolic diseases or malabsorption syndromes * Type 2 diabetes requiring the use of oral antidiabetic agents or insulin * Fasting triglycerides greater than 300 mg/dL * Fasting glucose greater than 126 mg/dL * History of eating disorders or other dietary patterns which are not consistent with the dietary intervention (e.g. vegetarians, very low fat diets, high protein diets) * Use of prescription of over-the-counter antiobesity medications or supplements during and for at least 6 months prior to the start of the study or a history of a surgical intervention for obesity * Active cardiovascular disease * Use of any tobacco products in the past 6 months * Use of oral or IV antibiotics during the month preceding the study or during the study * Unwillingness to abstain from vitamin, mineral, and herbal supplements for two weeks prior to the start of the study * Known (self-reported) allergy or adverse reaction to blackberries or gelatin * Unable or unwilling to give informed consent or communicate with study staff * Self-report of alcohol or substance abuse within the past 12 months and/or current acute treatment or rehabilitation program for these problems (long-term participation in Alcoholics Anonymous is not an exclusion) * Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol

Design outcomes

Primary

MeasureTime frame
Change from baseline in 8-oxo-dG levels after 5 daysDay 5

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026